Clinical relevance of copeptin plasma levels as a biomarker of disease severity and mortality in critically ill patients.

Copeptin plasma concentrations are significantly elevated in critically ill patients, correlate with disease severity and predict ICU and long-term outcome. Thus, copeptin could be a promising tool for prognostication and management of critically ill patients.